RIBON THERAPEUTICS, INC.

Profile

Company Names

RIBON THERAPEUTICS, INC.

Addresses

35 CAMBRIDGEPARK DRIVE, CAMBRIDGE, MA 02140

99 HAYDEN AVENUE, BUILDING D, SUITE 100, LEXINGTON, MA 02421

5 WARELAND RD., WELLESLEY, MA 02481

Phone Numbers

617-914-8700
917-543-8765
858 999 4413

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$119,065,525.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2022-12-22 
$25,000,000.00 
$25,000,000.00 
$0.00 
Equity 
4
2021-06-01 
$25,150,140.00 
$60,150,139.00 
$34,999,999.00 
Equity 
3
2018-12-21 
$25,415,384.00 
$65,000,000.00 
$39,584,616.00 
Equity 
2
2017-10-05 
$20,000,001.00 
$20,000,001.00 
$0.00 
Equity 
1
2015-11-19 
$23,500,000.00 
$23,500,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JAMES 
 
AUDIA 
DIRECTOR
PAUL 
 
BRANNELLY 
EXECUTIVE OFFICER
ANJA 
 
KOENIG 
DIRECTOR
JODIE 
 
MORRISON 
DIRECTOR
SVENNILSON 
 
PETER 
DIRECTOR
PRAKASH 
 
RAMAN 
EXECUTIVE OFFICER, DIRECTOR
VICTORIA 
M. 
RICHON 
EXECUTIVE OFFICER, DIRECTOR
EDWARD 
 
STEWART 
EXECUTIVE OFFICER
GARY 
 
SUTTON 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-12-22 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-06-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-05 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#